Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
Osipenko MA et al. | 2008 | intact cell/cell culture, fibroblasts (from mouse embryos), animal, mouse embryos | geomagnetic field, shielding/field deprivation | 200 nT |
Norimura T et al. | 1993 | intact cell/cell culture, human T-lymphocytes | static magnetic field, DC, co-exposure | 6.3 T |
Marędziak M et al. | 2017 | intact cell/cell culture, human adipose derived stem cells | static magnetic field | 500 mT |
Abusoglu G et al. | 2020 | intact cell/cell culture, human breast carcinoma cells (MDA MB-231 and MCF-7) | static magnetic field, co-exposure, also other exposures without EMF | - |
Amiri M et al. | 2018 | intact cell/cell culture, human glioblastoma cell line (U-87) | 50/60 Hz, static magnetic field, magnetic field, co-exposure, also other exposures without EMF | - |
Chen WT et al. | 2018 | intact cell/cell culture, human hepatocarcinoma cell line (HepG2) | static magnetic field, co-exposure, also other exposures without EMF | - |
Tenuzzo B et al. | 2009 | intact cell/cell culture, human lymphocytes | static magnetic field | 6 mT |
Reddig A et al. | 2015 | intact cell/cell culture, human lymphocytes | static magnetic field, MRI, co-exposure | - |
Tenuzzo B et al. | 2006 | intact cell/cell culture, human lymphocytes, mouse thymocytes, FRTL-5 cells (Fischer rat thyroid cells), Hep G2 cells (hepatic transformed cell line), HeLa cell line (human adenocarcinoma cell line), U937 (human leukemic monocyte cell line) and 3 DO cells (T cell hybridoma cell li | static magnetic field | 6 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.